Premium
Virax Biolabs Group Ltd (VRAX)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of immunology. It is developing a proprietary T-Cell Test technology with the intention of providing an immunolo... Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of immunology. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against major global viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.15 | -7.85340314136 | 1.91 | 2.1 | 1.75 | 187820 | 1.96211985 | CS |
| 4 | -0.34 | -16.1904761905 | 2.1 | 2.33 | 1.55 | 290295 | 1.80904151 | CS |
| 12 | -0.24 | -12 | 2 | 3.2 | 1.5143 | 397324 | 2.18828262 | CS |
| 26 | -3.26 | -64.9402390438 | 5.02 | 8.9999 | 1.46 | 3176085 | 4.22973839 | CS |
| 52 | 0.95 | 117.283950617 | 0.81 | 8.9999 | 0.6 | 2018480 | 3.72088236 | CS |
| 156 | -198.24 | -99.12 | 200 | 290 | 0.6 | 1465226 | 21.77554411 | CS |
| 260 | -198.24 | -99.12 | 200 | 290 | 0.6 | 1465226 | 21.77554411 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
